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To the editor
   The present problematic outbreak in Africa is the Ebola 
virus infection among local population in the capital of 
Guinea. It becomes a great concern since the present 
outbreak (March to April 2014) is considered to be the 
biggest outbreak, the first discovery of this viral infection[1]. 
A high death rate can be seen. Severe diarrhea and bleeding 
can be seen in almost all cases and death rate is very high 
(about 75%). Focusing on the present outbreak, there are 
many considerations on this situation. First, this outbreak 
occurs in urban area insead of a remote rural area, which 
is a warning sign for the seriousness and pandemic. The 
contamination of the disease from the remote limited foci 
to the big city can imply the chance of wide spreading. 
In fact, the disease is confirmed to spread out of Guinea 
to the nearby countries. Second, although there are many 
new datas on the pathogenesis of Ebola, which better 
than its first appearance, the diagnosis and treatment of 
the infection is still unsuccessful. Some recent reports 
mentioned new biomarkers to help with the diagnosis of 
Ebola but those biomarkers are still far from reality[2]. 
Third, until present, although there are several ongoing 
developments for Ebola vaccine, there is still no available 
vaccine for fighting the infection. The disease control during 
the outbreak becomes an extremely difficulty in public 
health. At present, the necessary things for the public 
health workers around the world include a) gathering basic 
knowledge and updating the situation of Ebola outbreaks, 
b) planning for preventive actions for possible cross border 
infection and infection carried by travelers from Africa, c) 
setting for an international collaboration or network to trace 
the spreading path of the infection and performing research 
and development to find effective diagnostic, therapeutic 
and preventive tools for Ebola.  
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